Lung cancer (non-small cell, advanced, inoperable) - liposomal cisplatin (with chemotherapy) [ID657]
Status In progress
Decision Selected
Process STA pre-2018
Referral date 01 November 2014

Provisional Schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC

Project Team

Associate Director: TBC
Communications manager: TBC
Project manager:


Technical Advisor: TBC
Technical Lead: TBC


Key events during the development of the guidance:

Date Update
27 January 2015 Following on from advice received from the company, the dates for this appraisal will be confirmed once regulatory approval timelines are established.
27 January 2015 Scoped as part of Batch 37

For further information on our processes and methods, please see our CHTE processes and methods manual